BSECompany UpdateMgmt Change10 Aug 2026
Syncom Formulations India Ltd-$
Revised Intimation for resignation of Mr. Vijay Shankarlal Bankda Managing Director Under Regulation 30 of SEBI (LODR) Regulations, 2015.
Syncom Formulations India Ltd has announced the resignation of its Managing Director, Mr. Vijay Shankarlal Bankda, effective August 11, 2026, citing leadership transition and succession planning.
BSECompany UpdateMgmt Change8 Aug 2026
Syncom Formulations India Ltd-$
Intimation for Resignation of Mr. Vijay Shankarlal Bankda Managing Director under Regulation 30 of SEBI (LODR) Regulations, 2015
Syncom Formulations India Ltd announces the resignation of its Managing Director, Mr. Vijay Shankarlal Bankda, effective August 11, 2026, as per Regulation 30 of SEBI (LODR) Regulations, 2015.
BSECompany UpdateMgmt Change8 Aug 2026
Syncom Formulations India Ltd-$
Intimation for Resignation of Mr. Rahul Vijay Bankda Chief Financial Officer (CFO) under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015
Syncom Formulations India Ltd has announced the resignation of its Chief Financial Officer (CFO), Mr. Rahul Vijay Bankda, effective August 11, 2026.
BSECompany UpdateMgmt Change8 Aug 2026
Syncom Formulations India Ltd-$
Intimation for Resignation of Mr. Kedarmal Shankarlal Bankda Whole-Time Director under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirement) Regulation, 2015
Syncom Formulations India Ltd has announced the resignation of Mr. Kedarmal Shankarlal Bankda as Whole-Time Director, effective August 11, 2026.
BSECorp. ActionResults6 Aug 2026
Syncom Formulations India Ltd-$
Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulation 2015, we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the company is scheduled to be held on Tuesday ....
Syncom Formulations India Ltd has scheduled its 2/2026-27 Board Meeting on August 11th to consider dividend, financial results, and other matters.
BSEBoard MeetingResults6 Aug 2026
Syncom Formulations India Ltd-$
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve we are pleased to ....
Syncom Formulations India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve standalone and consolidated unaudited financial results for the quarter ended 30th June, 2026, and to consider recommending the final dividend for the financial year ended 31st March, 2026.